Compare FOCL & APYX Stocks: Price Trends, ML Decisions, Charts, Trends, Technical Analysis and more.
Current Price
Current Price
| Metric | FOCL | APYX |
|---|---|---|
| Founded | N/A | 1982 |
| Country | France | United States |
| Employees | N/A | N/A |
| Industry | Biotechnology: Electromedical & Electrotherapeutic Apparatus | Medical/Dental Instruments |
| Sector | Health Care | Health Care |
| Exchange | Nasdaq | Nasdaq |
| Market Cap | 203.7M | 196.4M |
| IPO Year | 1998 | 1995 |
| Metric | FOCL | APYX |
|---|---|---|
| Price | $4.20 | $3.01 |
| Analyst Decision | | Strong Buy |
| Analyst Count | 0 | 4 |
| Target Price | N/A | ★ $6.50 |
| AVG Volume (30 Days) | ★ 199.0K | 144.1K |
| Earning Date | N/A | 05-07-2026 |
| Dividend Yield | N/A | N/A |
| EPS Growth | N/A | ★ 19.40 |
| EPS | N/A | ★ N/A |
| Revenue | ★ $70,527,000.00 | N/A |
| Revenue This Year | N/A | $11.93 |
| Revenue Next Year | N/A | $11.01 |
| P/E Ratio | N/A | ★ N/A |
| Revenue Growth | ★ 1.63 | N/A |
| 52 Week Low | $4.01 | $1.70 |
| 52 Week High | $6.40 | $5.08 |
| Indicator | FOCL | APYX |
|---|---|---|
| Relative Strength Index (RSI) | 37.55 | 37.47 |
| Support Level | $4.01 | $2.83 |
| Resistance Level | $4.50 | $3.29 |
| Average True Range (ATR) | 0.19 | 0.15 |
| MACD | 0.02 | 0.04 |
| Stochastic Oscillator | 58.16 | 52.69 |
Edap TMS SA, formerly known as FocalTherics, operates in the Robotic Focal Therapy industry. It develops, manufactures, and markets minimally invasive medical devices across various countries to treat various conditions using proprietary focused ultrasound technology. The company's flagship platform, Focal One Robotic HIFU, combines imaging, real-time treatment planning, robotic precision, and high intensity focused ultrasound (HIFU) technology. It is focused on expanding the clinical adoption of its patented focused ultrasound-based robotic therapy platforms through continued innovation, clinical evidence generation, physician education, and various market development initiatives.
Apyx Medical Corp is an energy technology medical device company. It specializes in developing, manufacturing, and marketing a range of cosmetic and surgical products and technologies, as well as related medical products used in doctor's offices, surgery centers, and hospitals. Its product offerings comprise Renuvion cosmetic technology, which offers plastic surgeons, facial plastic surgeons, and cosmetic physicians the ability to provide controlled heat to the tissue to achieve desired results. The J-Plasma system allows surgeons to operate with a high level of precision and virtually eliminates unintended tissue trauma. It operates in two segments namely: Surgical Aesthetics and Original Equipment Manufacturing (OEM). Its Surgical Aesthetics segment derives the majority of its revenue.